Idelvion IV 2000 (albutrepenonacog alpha), from CSL Behring, is an injectable recombinant factor IX albumin fusion protein indicated for the treatment and prophylaxis of bleeding in hemophilia B patients. It has a YJ code of 6343448D4029 and a standard of 2,000 IU 1 bottle (with dissolving liquid).
Idelvion IV 2000
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →